Where Will Vertex Pharmaceuticals Be in 1 Year? [The Motley Fool]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: The Motley Fool
Vertex Pharmaceuticals(NASDAQ:VRTXIn addition, Vertex's pipeline includes potential treatments for pain, sickle cell disease, and the blood disorder beta-thalassemia, but those studies are all still in Phases and . Therefore, Vertex's position a year from now will still depend on how its cystic fibrosis treatments are faring.Image source: Getty Images.Cystic fibrosis is a progressive genetic disease that affects various organs, but it's most known for its effect on the lungs. The disease is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that result in a defective or missing CFTR protein. The absence or faulty functioning of this protein leads to poor flow of salt and water through the cells of various organs.The FDA approved Trikafta -- a combination treatment composed of elexacaftor, tezacaftor, and ivacaftor -- to treat the underlying cause of the disease in patients and older who have at least one F08del mutation, the most common mutati
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex says JOURNAVX demonstrates ‘effective' pain management in study [Yahoo! Finance]Yahoo! Finance
- Vertex to Participate in Upcoming March Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Vertex to Participate in Upcoming March Investor ConferencesBusiness Wire
- Did Vertex's (VRTX) Earnings Beat and Advancing Pipeline Just Shift Its Investment Narrative? [Yahoo! Finance]Yahoo! Finance
- Vertex to Present New Data on JOURNAVX® That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 2/12/26 - Beat
VRTX
Sec Filings
- 3/6/26 - Form 4
- 3/4/26 - Form 4
- 3/4/26 - Form 144
- VRTX's page on the SEC website